CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	41.47	257.07	8.27	88.14	53.61
Short-Term Investments	646.96	484.93	179.41	55.34	-
Cash & Short-Term Investments	688.43	742	187.67	143.48	53.61
Cash Growth	266.82%	295.37%	30.80%	167.65%	-
Other Receivables	0.35	0.78	0.09	0.3	0
Receivables	0.35	0.78	0.09	0.3	0
Prepaid Expenses	12.41	11.43	6.36	3.42	4.8
Total Current Assets	701.19	754.21	194.12	147.21	58.41
Property, Plant & Equipment	1.3	0.49	0.49	0.51	0.2
Long-Term Deferred Charges	-	-	4.67	-	-
Other Long-Term Assets	0.52	0.09	0.02	0.03	0.09
Total Assets	728.18	754.8	199.3	147.75	58.69
Accounts Payable	6.73	6.52	3.24	0.99	1
Accrued Expenses	15.18	14.23	9.68	5.12	1.89
Current Portion of Long-Term Debt	-	-	-	8.97	2.94
Current Portion of Leases	0.26	0.19	0.22	0.19	0.07
Other Current Liabilities	0.48	0.44	1.12	0.17	0.07
Total Current Liabilities	22.64	21.37	14.25	15.43	5.98
Long-Term Debt	-	-	-	6.53	12.06
Long-Term Leases	0.78	0.05	0.24	0.26	0.05
Other Long-Term Liabilities	-	-	0.01	0.35	0.35
Total Liabilities	23.42	21.42	14.51	22.57	18.44
Common Stock	0.01	0.01	-	-	0
Additional Paid-In Capital	957.18	951.35	6.84	3.64	3.27
Retained Earnings	-252.43	-217.98	-129.94	-81.34	-45.89
Total Common Equity	704.76	733.38	-123.1	-77.69	-42.62
Shareholders' Equity	704.76	733.38	184.79	125.18	40.25
Total Liabilities & Equity	728.18	754.8	199.3	147.75	58.69
Total Debt	1.04	0.24	0.46	15.94	15.13
Net Cash (Debt)	687.4	741.76	187.21	127.54	38.48
Net Cash Growth	267.17%	296.21%	46.79%	231.45%	-
Net Cash Per Share	9.85	11.87	43.23	34.09	10.54
Filing Date Shares Outstanding	76.23	76.22	66.64	3.84	3.65
Total Common Shares Outstanding	76.22	76.15	5.22	3.84	3.65
Working Capital	678.55	732.84	179.87	131.78	52.43
Book Value Per Share	9.25	9.63	-23.57	-20.22	-11.67
Tangible Book Value	704.76	733.38	-123.1	-77.69	-42.62
Tangible Book Value Per Share	9.25	9.63	-23.57	-20.22	-11.67

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q